{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:00:00Z","timestamp":1794351600584,"version":"4.9.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000738","name":"Veterans Affairs","doi-asserted-by":"crossref","award":["CARA-009-16F9050"],"award-info":[{"award-number":["CARA-009-16F9050"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R18 HS026874"],"award-info":[{"award-number":["R18 HS026874"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 AG062582"],"award-info":[{"award-number":["R01 AG062582"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"American Health Association Health IT Strategically Focused Research Network","award":["R61 HL155498"],"award-info":[{"award-number":["R61 HL155498"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite the strong evidence supporting guideline-directed medical therapy (GDMT) in patients with heart failure with reduced ejection fraction (HFrEF), prescription rates in clinical practice are still lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A survey containing 20 clinical vignettes of patients with HFrEF was answered by a national sample of 127 cardiologists and 68 internal\/family medicine physicians. Each vignette had 4\u20135 options for adjusting GDMT and the option to make no medication changes. Survey respondents could only select one option. For analysis, responses were dichotomized to the answer of interest.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Cardiologists were more likely to make GDMT changes than general medicine physicians (91.8% vs. 82.0%; OR 1.84 [1.07\u20133.19];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.020). Cardiologists were more likely to initiate beta-blockers (46.3% vs. 32.0%; OR 2.38 [1.18\u20134.81],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.016), angiotensin receptor blocker\/neprilysin inhibitor (ARNI) (63.8% vs. 48.1%; OR 1.76 [1.01\u20133.09],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.047), and hydralazine and isosorbide dinitrate (HYD\/ISDN) (38.2% vs. 23.7%; OR 2.47 [1.48\u20134.12],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) compared to general medicine physicians. No differences were found in initiating angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker (ACEi\/ARBs), initiating mineralocorticoid receptor antagonist (MRA), sodium-glucose transporter protein 2 (SGLT2) inhibitors, digoxin, or ivabradine.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results demonstrate cardiologists were more likely to adjust GDMT than general medicine physicians. Future focus on improving GDMT prescribing should target providers other than cardiologists to improve care in patients with HFrEF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-024-03911-1","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T22:02:30Z","timestamp":1715378550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Differences in provider approach to initiating and titrating guideline directed medical therapy in heart failure with reduced ejection fraction"],"prefix":"10.1186","volume":"24","author":[{"given":"David J.","family":"Cordwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Guidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"Alhashimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Koelling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2910-1879","authenticated-orcid":false,"given":"Michael P.","family":"Dorsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,11]]},"reference":[{"issue":"8","key":"3911_CR1","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics\u20142022 update: a Report from the American Heart Association. Circulation. 2022;145(8):e153\u2013639.","journal-title":"Circulation"},{"issue":"14","key":"3911_CR2","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1056\/NEJMsa0803563","volume":"360","author":"SF Jencks","year":"2009","unstructured":"Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360(14):1418\u201328.","journal-title":"N Engl J Med"},{"issue":"2","key":"3911_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1161\/CIRCOUTCOMES.112.967356","volume":"6","author":"JH Retrum","year":"2013","unstructured":"Retrum JH, Boggs J, Hersh A, et al. Patient-identified factors related to heart failure readmissions. Circ Cardiovasc Qual Outcomes. 2013;6(2):171\u20137.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"7","key":"3911_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1001\/jamacardio.2020.0640","volume":"5","author":"M Fiuzat","year":"2020","unstructured":"Fiuzat M, Ezekowitz J, Alemayehu W, et al. Assessment of limitations to optimization of Guideline-Directed Medical Therapy in Heart failure from the GUIDE-IT Trial: a secondary analysis of a Randomized Clinical Trial. JAMA Cardiol. 2020;5(7):757\u201364.","journal-title":"JAMA Cardiol"},{"issue":"6","key":"3911_CR5","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA Guideline for the management of Heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017;70(6):776\u2013803.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"3911_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1056\/NEJM199108013250501","volume":"325","author":"SOLVD Investigators","year":"1991","unstructured":"Investigators SOLVD, Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325(5):293\u2013302.","journal-title":"N Engl J Med"},{"issue":"9169","key":"3911_CR7","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","author":"Effect of metoprolol CR\/XL in chronic heart failure","year":"1999","unstructured":"Effect of metoprolol CR\/XL in chronic heart failure. Metoprolol CR\/XL Randomised intervention trial in congestive heart failure (MERIT-HF). Lancet. 1999;353(9169):2001\u20137.","journal-title":"Lancet"},{"issue":"10","key":"3911_CR8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med. 1999;341(10):709\u201317.","journal-title":"N Engl J Med"},{"issue":"4","key":"3911_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","volume":"72","author":"SJ Greene","year":"2018","unstructured":"Greene SJ, Butler J, Albert NM, et al. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry. J Am Coll Cardiol. 2018;72(4):351\u201366.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"3911_CR10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S0735-1097(97)00176-9","volume":"30","author":"ME Edep","year":"1997","unstructured":"Edep ME, Shah NB, Tateo IM, Massie BM. Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines. J Am Coll Cardiol. 1997;30(2):518\u201326.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"3911_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1378\/chest.116.2.346","volume":"116","author":"EF Philbin","year":"1999","unstructured":"Philbin EF, Weil HF, Erb TA, Jenkins PL. Cardiology or primary care for heart failure in the community setting: process of care and clinical outcomes. Chest. 1999;116(2):346\u201354.","journal-title":"Chest"},{"issue":"8","key":"3911_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/jama.2017.10565","volume":"318","author":"GM Felker","year":"2017","unstructured":"Felker GM, Anstrom KJ, Adams KF, et al. Effect of natriuretic peptide-guided therapy on hospitalization or Cardiovascular Mortality in high-risk patients with heart failure and reduced ejection fraction: a Randomized Clinical Trial. JAMA. 2017;318(8):713\u201320.","journal-title":"JAMA"},{"issue":"2","key":"3911_CR13","first-page":"109","volume":"4","author":"M Fiuzat","year":"2016","unstructured":"Fiuzat M, Wojdyla D, Pina I, Adams K, Whellan D, O\u2019Connor CM. Heart rate or Beta-blocker dose? Association with outcomes in Ambulatory Heart failure patients with systolic dysfunction: results from the HF-ACTION Trial. JACC: Heart Fail. 2016;4(2):109\u201315.","journal-title":"JACC: Heart Fail"},{"issue":"5","key":"3911_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00392-015-0939-8","volume":"105","author":"MN Hirt","year":"2016","unstructured":"Hirt MN, Muttardi A, Helms TM, van den Bussche H, Eschenhagen T. General practitioners\u2019 adherence to chronic heart failure guidelines regarding medication: the GP-HF study. Clin Res Cardiol. 2016;105(5):441\u201350.","journal-title":"Clin Res Cardiol"},{"issue":"11","key":"3911_CR15","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/ejhf.173","volume":"16","author":"MLA Luttik","year":"2014","unstructured":"Luttik MLA, Jaarsma T, van Geel PP, et al. Long-term follow-up in optimally treated and stable heart failure patients: primary care vs. heart failure clinic. Results of the COACH-2 study. Eur J Heart Fail. 2014;16(11):1241\u20138.","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"3911_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.5414\/CP203203","volume":"56","author":"H Vaillant-Roussel","year":"2018","unstructured":"Vaillant-Roussel H, Pereira B, Gibot-Boeuf S, et al. How are patients with heart failure treated in primary care? Int J Clin Pharmacol Ther. 2018;56(8):347\u201357.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"3911_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1388-9842(03)00050-3","volume":"5","author":"FH Rutten","year":"2003","unstructured":"Rutten FH, Grobbee DE, Hoes AW. Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail. 2003;5:337\u201344.","journal-title":"Eur J Heart Fail"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-03911-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-03911-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-03911-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T22:03:57Z","timestamp":1715378637000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-03911-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,11]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3911"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-03911-1","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,11]]},"assertion":[{"value":"21 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed by the University of Michigan IRB and determined to be exempt. Informed consent was obtained from all subjects and\/or legal guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"247"}}